Share Price and Basic Stock Data
Last Updated: March 7, 2025, 8:12 pm
| PEG Ratio | 0.00 |
|---|
Competitors of Hindustan Agrigenetics Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Nagarjuna Agri Tech Ltd | 40.2 Cr. | 42.9 | 54.8/8.55 | 50.2 | 7.40 | 0.00 % | 9.22 % | 9.43 % | 10.0 |
| Hindustan Agrigenetics Ltd | 31.2 Cr. | 70.9 | 94.0/40.0 | 94.5 | 0.00 % | 4.96 % | 3.89 % | 10.0 | |
| Elegant Floriculture & Agrotech (India) Ltd | 15.3 Cr. | 5.95 | 7.76/5.12 | 13.4 | 8.25 | 0.00 % | 0.10 % | 0.10 % | 10.0 |
| Industry Average | 0 Cr | 39.92 | 52.70 | 7.83 | 0.00% | 4.76% | 4.47% | 10.00 |
Quarterly Result
| Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.03 | 0.00 | 0.04 | 0.00 | 0.03 | 0.00 | 0.04 | 0.00 | 0.03 | 0.00 | 0.04 | 0.00 | 0.03 |
| Expenses | 0.01 | 0.12 | 0.33 | 0.05 | 0.11 | 0.12 | 0.03 | 0.07 | -0.06 | 0.01 | 0.01 | 0.00 | 0.24 |
| Operating Profit | 0.02 | -0.12 | -0.29 | -0.05 | -0.08 | -0.12 | 0.01 | -0.07 | 0.09 | -0.01 | 0.03 | 0.00 | -0.21 |
| OPM % | 66.67% | -725.00% | -266.67% | 25.00% | 300.00% | 75.00% | -700.00% | ||||||
| Other Income | 0.01 | 0.03 | 0.09 | 0.14 | 0.15 | 0.03 | 0.14 | 0.16 | 0.15 | 0.15 | 0.02 | 0.15 | 0.24 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Profit before tax | 0.03 | -0.09 | -0.20 | 0.09 | 0.07 | -0.09 | 0.15 | 0.08 | 0.23 | 0.13 | 0.04 | 0.14 | 0.02 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | 0.02 | -0.09 | -0.20 | 0.09 | 0.07 | -0.09 | 0.15 | 0.07 | 0.22 | 0.13 | 0.04 | 0.14 | 0.02 |
| EPS in Rs |
Last Updated: March 3, 2025, 11:59 pm
Below is a detailed analysis of the quarterly data for Hindustan Agrigenetics Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:
- For Sales, as of Dec 2024, the value is ₹0.03 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Sep 2024) to ₹0.03 Cr., marking an increase of ₹0.03 Cr..
- For Expenses, as of Dec 2024, the value is ₹0.24 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.00 Cr. (Sep 2024) to ₹0.24 Cr., marking an increase of ₹0.24 Cr..
- For Operating Profit, as of Dec 2024, the value is ₹-0.21 Cr.. The value appears to be declining and may need further review. It has decreased from 0.00 Cr. (Sep 2024) to ₹-0.21 Cr., marking a decrease of 0.21 Cr..
- For OPM %, as of Dec 2024, the value is -700.00%. The value appears to be declining and may need further review. It has decreased from 0.00% (Sep 2024) to -700.00%, marking a decrease of 700.00%.
- For Other Income, as of Dec 2024, the value is ₹0.24 Cr.. The value appears strong and on an upward trend. It has increased from 0.15 Cr. (Sep 2024) to ₹0.24 Cr., marking an increase of ₹0.09 Cr..
- For Interest, as of Dec 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
- For Depreciation, as of Dec 2024, the value is ₹0.01 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.01 Cr..
- For Profit before tax, as of Dec 2024, the value is ₹0.02 Cr.. The value appears to be declining and may need further review. It has decreased from 0.14 Cr. (Sep 2024) to ₹0.02 Cr., marking a decrease of 0.12 Cr..
- For Tax %, as of Dec 2024, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00%.
- For Net Profit, as of Dec 2024, the value is ₹0.02 Cr.. The value appears to be declining and may need further review. It has decreased from 0.14 Cr. (Sep 2024) to ₹0.02 Cr., marking a decrease of 0.12 Cr..
- For EPS in Rs, as of Dec 2024, the value is 0.00. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded ₹0.00.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: February 28, 2025, 4:11 pm
| Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.05 | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 | 0.06 | 0.19 | 0.06 | 0.06 | 0.07 | 0.07 | 0.07 |
| Expenses | 0.12 | 0.12 | 0.26 | 0.12 | 0.16 | 0.21 | 0.22 | 0.59 | 0.19 | 0.23 | 0.72 | 0.39 | 0.26 |
| Operating Profit | -0.07 | -0.06 | -0.20 | -0.06 | -0.10 | -0.16 | -0.16 | -0.40 | -0.13 | -0.17 | -0.65 | -0.32 | -0.19 |
| OPM % | -140.00% | -100.00% | -333.33% | -100.00% | -166.67% | -320.00% | -266.67% | -210.53% | -216.67% | -283.33% | -928.57% | -457.14% | -271.43% |
| Other Income | -0.03 | 0.05 | 0.30 | 0.95 | 0.28 | 0.19 | 0.04 | 0.04 | -0.05 | 0.06 | 10.56 | 0.96 | 0.56 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.04 | 0.04 |
| Profit before tax | -0.12 | -0.03 | 0.09 | 0.88 | 0.17 | 0.02 | -0.13 | -0.37 | -0.18 | -0.11 | 9.91 | 0.60 | 0.33 |
| Tax % | -66.67% | 133.33% | 0.00% | 25.00% | 35.29% | 3,100.00% | -7.69% | -186.49% | -16.67% | -9.09% | 0.50% | 23.33% | |
| Net Profit | -0.04 | -0.07 | 0.09 | 0.66 | 0.11 | -0.59 | -0.12 | 0.33 | -0.15 | -0.10 | 9.86 | 0.47 | 0.33 |
| EPS in Rs | |||||||||||||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -75.00% | 228.57% | 633.33% | -83.33% | -636.36% | 79.66% | 375.00% | -145.45% | 33.33% | 9960.00% | -95.23% |
| Change in YoY Net Profit Growth (%) | 0.00% | 303.57% | 404.76% | -716.67% | -553.03% | 716.02% | 295.34% | -520.45% | 178.79% | 9926.67% | -10055.23% |
Hindustan Agrigenetics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 3% |
| 3 Years: | 5% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 24% |
| 5 Years: | 78% |
| 3 Years: | 89% |
| TTM: | -6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 42% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 2% |
| 3 Years: | 1% |
| Last Year: | 4% |
Last Updated: Unknown
Balance Sheet
Last Updated: December 14, 2024, 1:30 pm
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 |
| Reserves | -2.37 | -2.44 | -2.35 | -1.69 | -1.63 | -2.22 | -2.48 | -2.16 | -2.30 | -2.40 | 7.46 | 7.93 | 8.11 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.99 | 0.98 | 1.01 | 0.23 | 0.15 | 0.16 | 0.22 | 0.28 | 0.85 | 6.19 | 0.50 | 0.42 | 0.45 |
| Total Liabilities | 3.02 | 2.94 | 3.06 | 2.94 | 2.92 | 2.34 | 2.14 | 2.52 | 2.95 | 8.19 | 12.36 | 12.75 | 12.96 |
| Fixed Assets | 0.38 | 0.36 | 0.36 | 0.35 | 0.34 | 0.35 | 0.36 | 0.36 | 0.35 | 0.35 | 0.05 | 0.19 | 0.17 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 1.34 | 1.35 | 1.45 | 1.57 | 1.58 | 1.59 | 1.38 | 0.21 | 1.35 | 1.75 | 0.85 | 1.97 | 4.22 |
| Other Assets | 1.30 | 1.23 | 1.25 | 1.02 | 1.00 | 0.40 | 0.40 | 1.95 | 1.25 | 6.09 | 11.46 | 10.59 | 8.57 |
| Total Assets | 3.02 | 2.94 | 3.06 | 2.94 | 2.92 | 2.34 | 2.14 | 2.52 | 2.95 | 8.19 | 12.36 | 12.75 | 12.96 |
Below is a detailed analysis of the balance sheet data for Hindustan Agrigenetics Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is ₹4.40 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹4.40 Cr..
- For Reserves, as of Sep 2024, the value is ₹8.11 Cr.. The value appears strong and on an upward trend. It has increased from ₹7.93 Cr. (Mar 2024) to ₹8.11 Cr., marking an increase of 0.18 Cr..
- For Borrowings, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded ₹0.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is ₹0.45 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹0.42 Cr. (Mar 2024) to ₹0.45 Cr., marking an increase of 0.03 Cr..
- For Total Liabilities, as of Sep 2024, the value is ₹12.96 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹12.75 Cr. (Mar 2024) to ₹12.96 Cr., marking an increase of 0.21 Cr..
- For Fixed Assets, as of Sep 2024, the value is ₹0.17 Cr.. The value appears to be declining and may need further review. It has decreased from ₹0.19 Cr. (Mar 2024) to ₹0.17 Cr., marking a decrease of 0.02 Cr..
- For CWIP, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹0.00 Cr..
- For Investments, as of Sep 2024, the value is ₹4.22 Cr.. The value appears strong and on an upward trend. It has increased from ₹1.97 Cr. (Mar 2024) to ₹4.22 Cr., marking an increase of 2.25 Cr..
- For Other Assets, as of Sep 2024, the value is ₹8.57 Cr.. The value appears to be declining and may need further review. It has decreased from ₹10.59 Cr. (Mar 2024) to ₹8.57 Cr., marking a decrease of 2.02 Cr..
- For Total Assets, as of Sep 2024, the value is ₹12.96 Cr.. The value appears strong and on an upward trend. It has increased from ₹12.75 Cr. (Mar 2024) to ₹12.96 Cr., marking an increase of 0.21 Cr..
Notably, the Reserves (₹8.11 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.07 | -0.06 | -0.20 | -0.06 | -0.10 | -0.16 | -0.16 | -0.40 | -0.13 | -0.17 | -0.65 | -0.32 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Days | -6,278.00 | -5,170.83 | -5,353.33 | -730.00 | -243.33 | -365.00 | -608.33 | 883.68 | -4,501.67 | -36,925.83 | -1,668.57 | 9,177.14 |
| ROCE % | 0.00% | -3.51% | -2.00% | 33.61% | 0.00% | 0.81% | -1.95% | -13.46% | -5.99% | -7.80% | -1.73% | 4.96% |
This stock is not held by any mutual fund
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.07 | 22.40 | -0.22 | -0.33 | 0.74 |
| Diluted EPS (Rs.) | 1.07 | 22.40 | -0.22 | -0.33 | 0.74 |
| Cash EPS (Rs.) | 1.15 | 22.41 | -0.21 | -0.32 | 0.75 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 27.65 | 26.58 | 4.17 | 4.39 | 4.73 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 28.02 | 26.95 | 4.55 | 4.77 | 5.10 |
| Revenue From Operations / Share (Rs.) | 2.35 | 24.43 | 0.28 | 0.13 | 0.42 |
| PBDIT / Share (Rs.) | 1.46 | 22.52 | -0.24 | -0.40 | -0.81 |
| PBIT / Share (Rs.) | 1.38 | 22.52 | -0.25 | -0.40 | -0.82 |
| PBT / Share (Rs.) | 1.38 | 22.52 | -0.25 | -0.40 | -0.82 |
| Net Profit / Share (Rs.) | 1.07 | 22.40 | -0.22 | -0.33 | 0.74 |
| PBDIT Margin (%) | 62.20 | 92.19 | -85.45 | -288.85 | -191.48 |
| PBIT Margin (%) | 58.64 | 92.17 | -87.40 | -295.28 | -194.88 |
| PBT Margin (%) | 58.64 | 92.17 | -87.40 | -295.28 | -194.88 |
| Net Profit Margin (%) | 45.44 | 91.71 | -76.62 | -238.42 | 174.45 |
| Return on Networth / Equity (%) | 3.85 | 84.29 | -5.28 | -7.52 | 15.71 |
| Return on Capital Employeed (%) | 4.91 | 83.54 | -5.53 | -8.59 | -16.27 |
| Return On Assets (%) | 3.68 | 79.74 | -1.18 | -4.94 | 12.92 |
| Asset Turnover Ratio (%) | 0.08 | 1.05 | 0.02 | 0.02 | 0.08 |
| Current Ratio (X) | 27.72 | 22.40 | 1.11 | 1.92 | 4.38 |
| Quick Ratio (X) | 27.72 | 22.40 | 1.11 | 1.92 | 4.38 |
| Enterprise Value (Cr.) | 13.01 | -8.02 | 0.00 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 12.59 | -0.74 | 0.00 | 0.00 | 0.00 |
| EV / EBITDA (X) | 20.24 | -0.80 | 0.00 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 21.77 | 0.20 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 1.85 | 0.19 | 0.00 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 21.77 | 0.20 | 0.00 | 0.00 | 0.00 |
| EarningsYield | 0.02 | 4.44 | 0.00 | 0.00 | 0.00 |
After reviewing the key financial ratios for Hindustan Agrigenetics Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 1.07. This value is below the healthy minimum of 5. It has decreased from 22.40 (Mar 23) to 1.07, marking a decrease of 21.33.
- For Diluted EPS (Rs.), as of Mar 24, the value is 1.07. This value is below the healthy minimum of 5. It has decreased from 22.40 (Mar 23) to 1.07, marking a decrease of 21.33.
- For Cash EPS (Rs.), as of Mar 24, the value is 1.15. This value is below the healthy minimum of 3. It has decreased from 22.41 (Mar 23) to 1.15, marking a decrease of 21.26.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 27.65. It has increased from 26.58 (Mar 23) to 27.65, marking an increase of 1.07.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 28.02. It has increased from 26.95 (Mar 23) to 28.02, marking an increase of 1.07.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 2.35. It has decreased from 24.43 (Mar 23) to 2.35, marking a decrease of 22.08.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 1.46. This value is below the healthy minimum of 2. It has decreased from 22.52 (Mar 23) to 1.46, marking a decrease of 21.06.
- For PBIT / Share (Rs.), as of Mar 24, the value is 1.38. This value is within the healthy range. It has decreased from 22.52 (Mar 23) to 1.38, marking a decrease of 21.14.
- For PBT / Share (Rs.), as of Mar 24, the value is 1.38. This value is within the healthy range. It has decreased from 22.52 (Mar 23) to 1.38, marking a decrease of 21.14.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 1.07. This value is below the healthy minimum of 2. It has decreased from 22.40 (Mar 23) to 1.07, marking a decrease of 21.33.
- For PBDIT Margin (%), as of Mar 24, the value is 62.20. This value is within the healthy range. It has decreased from 92.19 (Mar 23) to 62.20, marking a decrease of 29.99.
- For PBIT Margin (%), as of Mar 24, the value is 58.64. This value exceeds the healthy maximum of 20. It has decreased from 92.17 (Mar 23) to 58.64, marking a decrease of 33.53.
- For PBT Margin (%), as of Mar 24, the value is 58.64. This value is within the healthy range. It has decreased from 92.17 (Mar 23) to 58.64, marking a decrease of 33.53.
- For Net Profit Margin (%), as of Mar 24, the value is 45.44. This value exceeds the healthy maximum of 10. It has decreased from 91.71 (Mar 23) to 45.44, marking a decrease of 46.27.
- For Return on Networth / Equity (%), as of Mar 24, the value is 3.85. This value is below the healthy minimum of 15. It has decreased from 84.29 (Mar 23) to 3.85, marking a decrease of 80.44.
- For Return on Capital Employeed (%), as of Mar 24, the value is 4.91. This value is below the healthy minimum of 10. It has decreased from 83.54 (Mar 23) to 4.91, marking a decrease of 78.63.
- For Return On Assets (%), as of Mar 24, the value is 3.68. This value is below the healthy minimum of 5. It has decreased from 79.74 (Mar 23) to 3.68, marking a decrease of 76.06.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.08. It has decreased from 1.05 (Mar 23) to 0.08, marking a decrease of 0.97.
- For Current Ratio (X), as of Mar 24, the value is 27.72. This value exceeds the healthy maximum of 3. It has increased from 22.40 (Mar 23) to 27.72, marking an increase of 5.32.
- For Quick Ratio (X), as of Mar 24, the value is 27.72. This value exceeds the healthy maximum of 2. It has increased from 22.40 (Mar 23) to 27.72, marking an increase of 5.32.
- For Enterprise Value (Cr.), as of Mar 24, the value is 13.01. It has increased from -8.02 (Mar 23) to 13.01, marking an increase of 21.03.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 12.59. This value exceeds the healthy maximum of 3. It has increased from -0.74 (Mar 23) to 12.59, marking an increase of 13.33.
- For EV / EBITDA (X), as of Mar 24, the value is 20.24. This value exceeds the healthy maximum of 15. It has increased from -0.80 (Mar 23) to 20.24, marking an increase of 21.04.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 21.77. This value exceeds the healthy maximum of 3. It has increased from 0.20 (Mar 23) to 21.77, marking an increase of 21.57.
- For Price / BV (X), as of Mar 24, the value is 1.85. This value is within the healthy range. It has increased from 0.19 (Mar 23) to 1.85, marking an increase of 1.66.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 21.77. This value exceeds the healthy maximum of 3. It has increased from 0.20 (Mar 23) to 21.77, marking an increase of 21.57.
- For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 4.44 (Mar 23) to 0.02, marking a decrease of 4.42.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Hindustan Agrigenetics Ltd:
- Net Profit Margin: 45.44%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 4.91% (Industry Average ROCE: 4.76%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 3.85% (Industry Average ROE: 4.47%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 27.72
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 94.5 (Industry average Stock P/E: 52.7)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 45.44%
About the Company - Qualitative Analysis
Hindustan Agrigenetics Ltd. is a Public Limited Listed company incorporated on 25/07/1990 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L01119DL1990PLC040979 and registration number is 040979. Currently company belongs to the Industry of Floriculture. Company's Total Operating Revenue is Rs. 1.03 Cr. and Equity Capital is Rs. 4.40 Cr. for the Year ended 31/03/2024.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Floriculture | 806, Meghdoot, New Delhi Delhi 110019 | hindustanagrigenetics@gmail.com http://www.hindustanagrigenetics.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Pranav Kapur | Chairman |
| Mr. Pritam Kapur | Managing Director |
| Ms. Chandni Kapur | Director & CFO |
| Ms. Mannu Kohli | Independent Director |
| Mr. Sunny Srivastava | Independent Director |
| Mr. Naren Parsai | Independent Director |
FAQ
What is the latest intrinsic value of Hindustan Agrigenetics Ltd?
The latest intrinsic value of Hindustan Agrigenetics Ltd is ₹0.00. Unfortunately, additional data is unavailable.
What is the Market Cap of Hindustan Agrigenetics Ltd?
The Market Cap of Hindustan Agrigenetics Ltd is 31.2 Cr..
What is the current Stock Price of Hindustan Agrigenetics Ltd as on 10 March 2025?
The current stock price of Hindustan Agrigenetics Ltd as on 10 March 2025 is ₹70.9.
What is the High / Low of Hindustan Agrigenetics Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of Hindustan Agrigenetics Ltd stocks is ₹94.0/40.0.
What is the Stock P/E of Hindustan Agrigenetics Ltd?
The Stock P/E of Hindustan Agrigenetics Ltd is 94.5.
What is the Book Value of Hindustan Agrigenetics Ltd?
The Book Value of Hindustan Agrigenetics Ltd is .
What is the Dividend Yield of Hindustan Agrigenetics Ltd?
The Dividend Yield of Hindustan Agrigenetics Ltd is 0.00 %.
What is the ROCE of Hindustan Agrigenetics Ltd?
The ROCE of Hindustan Agrigenetics Ltd is 4.96 %.
What is the ROE of Hindustan Agrigenetics Ltd?
The ROE of Hindustan Agrigenetics Ltd is 3.89 %.
What is the Face Value of Hindustan Agrigenetics Ltd?
The Face Value of Hindustan Agrigenetics Ltd is 10.0.